COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,870 Articles (22,568 medRxiv, 8,302 bioRxiv)

Most recent first Previous |  Page 801: Articles 8001-8010  | Next

Time series analysis of SARS-CoV-2 genomes and correlations among highly prevalent mutations
Periwal, N., Rathod, S. B., Sarma, S., Johar, G., Jain, A., Barnwal, R. P., Srivastava, K. R., Kaur, B., Arora, P., Sood, V.
10.1101/2022.04.05.487114 — Posted: 2022-04-05
Combination of Baricitinib plus Remdesivir and Dexamethasone improves time to recovery and mortality among hospitalized patients with severe COVID-19 infection
Perez Gutierrez, V. A., Shah, V., Afzal, A., Khalid, A., Yangco, A., Ocrospoma, S., Cemalovic, N., Pillai, A., Kasubhai, M., Dimitrov, V., Menon, V.
10.1101/2022.04.04.22273425 — Posted: 2022-04-05
Determinants of mortality among COVID-19 patients with diabetes mellitus in Addis Ababa, Ethiopia, 2022: An unmatched case-control study
Sibhat, M. M., Getnet, M. T., Chane, W. Z., Gebeyehu, K. T., Habtamu, A. S., Mezgebu, T. A., Asmare, H. B., Ambaw, M. M., Getahun, E. M.
10.1101/2022.04.04.22273344 — Posted: 2022-04-05
Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study
Bouton, T. C., Atarere, J., Turcinovic, J., Seitz, S., Sher-Jan, C., Gilbert, M., White, L., Zhou, Z., Hossain, M. M., Overbeck, V., Doucette-Stamm, L., Platt, J., Landsberg, H. E., Hamer, D. H., Klapperich, C. M., Jacobson, K. R., Connor, J. H.
10.1101/2022.04.04.22273429 — Posted: 2022-04-05
Classification of Omicron BA.1, BA.1.1 and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data
Hirotsu, Y., Maejima, M., Shibusawa, M., Natori, Y., Nagakubo, Y., Hosaka, K., Sueki, H., Mochizuki, H., Tsutsui, T., Kakizaki, Y., Miyashita, Y., Omata, M.
10.1101/2022.04.03.22273268 — Posted: 2022-04-05
Low-dose IL-2 reduces IL-21+ T cells and induces a long-lived anti-inflammatory gene expression signature inversely modulated in COVID-19 patients
Zhang, J.-Y., Hamey, F., Trzupek, D., Mickunas, M., Lee, M., Godfrey, L., Yang, J. H. M., Pekalski, M. L., Kennet, J., Waldron-Lynch, F., Evans, M. L., Tree, T. I. M., Wicker, L. S., Todd, J. A., Ferreira, R. C.
10.1101/2022.04.05.22273167 — Posted: 2022-04-05
Evolution of Delta variant by non-Spike signature co-appearing mutations: trailblazer of COVID-19 disease outcome
Banerjee, A., Mazumder, A., Roy, J., Majumdar, A., Chatterjee, A., Biswas, N. K., Chawla-Sarkar, M., Maitra, A., Dutta, S., Das, S.
10.1101/2022.04.05.487103 — Posted: 2022-04-05
Workplace ventilation improvement to address coronavirus disease 2019 cluster occurrence in a manufacturing factory
Kitamura, H., Ishigaki, Y., Ohashi, H., Yokogawa, S.
10.1101/2022.04.04.22271935 — Posted: 2022-04-05
Targeted protein S-nitrosylation of ACE2 as potential treatment to prevent spread of SARS-CoV-2 infection
Oh, C.-k., Nakamura, T., Beutler, N., Zhang, X., Pina-Crespo, J., Talantova, M., Ghatak, S., Trudler, D., Carnevale, L. N., McKercher, S. R., Bakowski, M. A., Diedrich, J. K., Roberts, A. J., Woods, A. K., Chi, V., Gupta, A. K., Rosenfeld, M. A., Kearns, F. L., Casalino, L., Shaabani, N., Liu, H., Wilson, I. A., Amaro, R. E., Burton, D. R., Yates, J. R., Becker, C., Rogers, T. F., Chatterjee, A. K., Lipton, S. A.
10.1101/2022.04.05.487060 — Posted: 2022-04-05
Screening of SARS-CoV-2 Antivirals Through a Cell-Based RNA-Dependent RNA Polymerase (RdRp) Reporter Assay
Uppal, T., Tuffo, K., Khaiboullina, S., Reganti, S., PANDORI, M. C., Verma, S. C.
10.1101/2022.04.04.486994 — Posted: 2022-04-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).